Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesley Burks

Showing results (151-160 of 279) with videos related to

Pageof 28
Sort By:
Pediatrics|October 12, 2011
NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric populationA Wesley Burks, Stacie M Jones, Joshua A Boyce, et al.
Frontiers in Immunology|October 17, 2022
Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergyJada Suber, Yugen Zhang, Ping Ye, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 27, 2016
Eosinophilic esophagitis during peanut oral immunotherapy with omalizumabCaitlin M Burk, Evan S Dellon, Pamela H Steele, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2012
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapyMichael Kulis, Katie Saba, Edwin H Kim, et al.
International Archives of Allergy and Immunology|August 8, 2013
Allergenic properties of enzymatically hydrolyzed peanut flour extractsXiaolei Shi, Rishu Guo, Brittany L White, et al.
Pediatrics|August 27, 2009
Profiling families enrolled in food allergy immunotherapy studiesAudrey DunnGalvin, Wen Chin Chang, Susan Laubach, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical TrialsJelena P Berglund, Nicole Szczepanski, Anusha Penumarti, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2011
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergyHugh A Sampson, Donald Y M Leung, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
The Journal of Pediatrics|March 27, 2018
Application of Assessment Metrics for an Academic Department Faculty Development ProgramTerry L Noah, Sue Tolleson-Rinehart, Samantha Meltzer-Brody, et al.
Pageof 28

Showing results (151-160 of 279) with videos related to

Sort By:
Pageof 28
Pediatrics|October 12, 2011
NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric populationA Wesley Burks, Stacie M Jones, Joshua A Boyce, et al.
Frontiers in Immunology|October 17, 2022
Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergyJada Suber, Yugen Zhang, Ping Ye, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 27, 2016
Eosinophilic esophagitis during peanut oral immunotherapy with omalizumabCaitlin M Burk, Evan S Dellon, Pamela H Steele, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2012
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapyMichael Kulis, Katie Saba, Edwin H Kim, et al.
International Archives of Allergy and Immunology|August 8, 2013
Allergenic properties of enzymatically hydrolyzed peanut flour extractsXiaolei Shi, Rishu Guo, Brittany L White, et al.
Pediatrics|August 27, 2009
Profiling families enrolled in food allergy immunotherapy studiesAudrey DunnGalvin, Wen Chin Chang, Susan Laubach, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical TrialsJelena P Berglund, Nicole Szczepanski, Anusha Penumarti, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2011
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergyHugh A Sampson, Donald Y M Leung, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
The Journal of Pediatrics|March 27, 2018
Application of Assessment Metrics for an Academic Department Faculty Development ProgramTerry L Noah, Sue Tolleson-Rinehart, Samantha Meltzer-Brody, et al.
Pageof 28